LADENBURG THALMANN FINANCIAL SERVICES INC. - GENETIC TECHNOLOGIES LTD ownership

GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 13 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of GENETIC TECHNOLOGIES LTD
ValueSharesWeighting
Q3 2018$3,0000.0%2,7500.0%0.00%
Q2 2018$3,0000.0%2,7500.0%0.00%
Q1 2018$3,0000.0%2,7500.0%0.00%
Q4 2017$3,000
+50.0%
2,7500.0%0.00%
Q3 2017$2,0000.0%2,7500.0%0.00%
Q2 2017$2,000
-33.3%
2,7500.0%0.00%
Q1 2017$3,0000.0%2,7500.0%0.00%
Q4 2016$3,000
-40.0%
2,7500.0%0.00%
Q3 2016$5,000
-16.7%
2,7500.0%0.00%
Q2 2016$6,0000.0%2,7500.0%0.00%
Q1 2016$6,000
-14.3%
2,7500.0%0.00%
Q4 2015$7,000
+40.0%
2,7500.0%0.00%
Q3 2015$5,000
-37.5%
2,7500.0%0.00%
Q2 2015$8,0002,7500.00%
Other shareholders
GENETIC TECHNOLOGIES LTD shareholders Q1 2017
NameSharesValueWeighting ↓
Alpine Global Management, LLC 28,437$30,0000.01%
Virtu Financial LLC 37,505$39,0000.00%
Renaissance Technologies 982,980$1,022,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,750$3,0000.00%
JANE STREET GROUP, LLC 13,527$14,0000.00%
UBS Group AG 3,398$3,0000.00%
CITIGROUP INC 300$00.00%
MORGAN STANLEY 1,520$2,0000.00%
Financial Architects, Inc 350$00.00%
Cambridge Investment Research Advisors, Inc. 12,000$12,0000.00%
View complete list of GENETIC TECHNOLOGIES LTD shareholders